BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27338827)

  • 21. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation.
    Cohen JM; Sebire NJ; Harvey J; Gaspar HB; Cathy C; Jones A; Rao K; Cubitt D; Amrolia PJ; Davies EG; Veys P
    Blood; 2007 Sep; 110(6):2209-14. PubMed ID: 17502458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
    Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
    Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature.
    Ricci S; Abu-Rumeileh S; Campagna N; Barbati F; Stagi S; Canessa C; Lodi L; Palterer B; Maggi L; Matucci A; Vultaggio A; Annunziato F; Azzari C
    Front Immunol; 2023; 14():1224603. PubMed ID: 37600787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-uniform
    Burns DM; Ryan GB; Harvey CM; Nagy E; Hughes S; Murray PG; Russell NH; Fox CP; Long HM
    Front Immunol; 2019; 10():2489. PubMed ID: 31736946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation.
    Mansour R; El-Orfali Y; Saidu A; Al-Kalamouni H; Mardirossian H; Hanna-Wakim R; Abboud M; Massaad MJ
    Clin Immunol; 2023 Dec; 257():109813. PubMed ID: 37898412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation.
    Hoshino A; Takashima T; Yoshida K; Morimoto A; Kawahara Y; Yeh TW; Okano T; Yamashita M; Mitsuiki N; Imai K; Sakatani T; Nakazawa A; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Morio T; Kanegane H
    J Infect Dis; 2018 Jul; 218(5):825-834. PubMed ID: 29684201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma.
    Lev A; Asleh M; Levy S; Lee YN; Simon AJ; Stepensky P; Nalbandyan K; Nahum A; Ben-Harosh M; Yablonski D; Broides A; Somech R
    J Clin Immunol; 2023 Apr; 43(3):625-635. PubMed ID: 36474126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.
    Simon M; Bartram CR; Friedrich W; Arnold R; Schmeiser T; Hampl W; Müller-Hermelink HK; Heymer B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):307-19. PubMed ID: 1685038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency.
    Kuehn HS; Bernasconi A; Niemela JE; Almejun MB; Gallego WAF; Goel S; Stoddard JL; Sánchez RGP; Franco CAA; Oleastro M; Grunebaum E; Ballas Z; Cunningham-Rundles C; Fleisher TA; Franco JL; Danielian S; Rosenzweig SD
    J Clin Immunol; 2020 Nov; 40(8):1093-1101. PubMed ID: 32813180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.
    Lindsay J; Yong MK; Greenwood M; Kong DCM; Chen SCA; Rawlinson W; Slavin M
    Rev Med Virol; 2020 Jul; 30(4):e2108. PubMed ID: 32301566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.
    Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A
    Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling.
    Menter T; Dickenmann M; Juskevicius D; Steiger J; Dirnhofer S; Tzankov A
    Hematol Oncol; 2017 Jun; 35(2):187-197. PubMed ID: 26799990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
    de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic susceptibility to EBV infection: insights from inborn errors of immunity.
    Tangye SG
    Hum Genet; 2020 Jun; 139(6-7):885-901. PubMed ID: 32152698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.
    Arjunaraja S; Angelus P; Su HC; Snow AL
    Front Immunol; 2018; 9():198. PubMed ID: 29472930
    [No Abstract]   [Full Text] [Related]  

  • 39. Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in
    Anim M; Sogkas G; Schmidt G; Dubrowinskaja N; Witte T; Schmidt RE; Atschekzei F
    Front Immunol; 2021; 12():767188. PubMed ID: 35003082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
    Tuijnenburg P; Lango Allen H; Burns SO; Greene D; Jansen MH; Staples E; Stephens J; Carss KJ; Biasci D; Baxendale H; Thomas M; Chandra A; Kiani-Alikhan S; Longhurst HJ; Seneviratne SL; Oksenhendler E; Simeoni I; de Bree GJ; Tool ATJ; van Leeuwen EMM; Ebberink EHTM; Meijer AB; Tuna S; Whitehorn D; Brown M; Turro E; Thrasher AJ; Smith KGC; Thaventhiran JE; Kuijpers TW;
    J Allergy Clin Immunol; 2018 Oct; 142(4):1285-1296. PubMed ID: 29477724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.